Vancouver Clinic Earns Therapeutic License to Administer New Drug to Treat Prostate Cancer
“We are thrilled to offer this novel treatment in Canada to help prolong lives” VANCOUVER, BC, March 7, 2023 /CNW/ – INITIO Medical Group is the first private nuclear medicine facility in Canada to be awarded a therapeutic license to administer Lutetium-177-PSMA (prostate specific membrane antigen) for the treatment of advanced prostate cancer, specifically “metastatic […]
First Patients in Canada Imaged with Illuccix®: Now Commercially Available Nationwide.
MELBOURNE, Australia, May 1, 2023 /CNW/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces first patients have been imaged in Canada with its commercially available prostate cancer imaging agent, Illuccix® [kit for the preparation of gallium (68Ga) PSMA-11 for intravenous injection]. With Illuccix now available nationwide in Canada through Telix’s partner Isologic […]